Sertraline Hydrochloride Tablet
Product Images NDC 50090-7694

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 50090-7694). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907694)

Packaging label for SERTRALINE HYDROCHLORIDE 100 mg oral tablets by A-S Medication Solutions. The label shows the product NDC 50090-7694-0, lot number, storage instructions to keep at 20 to 25 degrees Celsius, and indicates the package contains 90 tablets. It includes a dosage instruction to see the package insert.*

FDA Label Image

Image Description (Struct)

Chemical structure of sertraline hydrochloride, showing its molecular arrangement including a bicyclic ring with two chlorine atoms and an amine group methylated at one nitrogen.*

FDA Label Image

Table 3 (Table 3)

A table titled 'Common Adverse Reactions in Pooled Placebo-Controlled Trials in Adults with MDD, OCD, PD, PTSD, SAD, and PMDD' comparing the incidence percentages of various adverse reactions between sertraline hydrochloride and placebo groups. It lists disorders across categories such as cardiac, eye, gastrointestinal, nervous system, psychiatric, reproductive, and skin disorders, showing higher rates of reactions like nausea, diarrhea, dizziness, insomnia, and ejaculation failure in the sertraline hydrochloride group.*

FDA Label Image

Table1 (Table1)

A data table titled 'Recommended Daily Dosage of sertraline hydrochloride in Patients with MDD, OCD, PD, PTSD, and SAD.' It lists starting doses and therapeutic ranges for adults and pediatric patients with various indications, including Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD). Dosages range from 25 mg to 50 mg starting doses, with a therapeutic range of 50-200 mg noted for some indications.*

FDA Label Image

Table2 (Table2)

A data table showing risk differences in number of suicidal thoughts or behaviors per 1000 patients treated, comparing antidepressants to placebo across age ranges. It displays increases for patients under 25 years and decreases for patients aged 25 and older.*

FDA Label Image

Image Description (Table4)

A data table showing the most common sexual adverse reactions (≥2% and twice placebo) in men and women from sertraline hydrochloride pooled controlled trials. It compares the percentages of men and women reporting issues such as ejaculation failure, decreased libido, erectile dysfunction, and male sexual dysfunction versus placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.